section name header

Basics

Clinical Manifestations

Warning Signs

  • New, changing (evolving), or unusual nevi; the most common sign of melanoma.

  • Symptomatic nevi (e.g., those that itch, burn, or are painful).

  • An initial slow horizontal growth phase, if left untreated, is followed in months or years by a vertical growth phase (lesions that extend vertically in the skin), which indicates invasive disease and potential metastasis.

  • White coloration may indicate regression or scarring.

Clinical Variant

Lentigo Maligna and Lentigo Maligna Melanoma !!navigator!!

  • Lentigo maligna (LM) is a type of lentigo that is found on the face of elderly patients with chronically sun-damaged skin. LM is considered to be a potential precursor to melanoma (Fig. 31.35).

  • LM lesions are characterized by:

    • a gradually enlarging tan to brown macule with irregular borders.

    • slow growth over 5 to 20 years.

    • an irregular color and border.

    • when an LM invades the dermis, it is then referred to as a lentigo maligna melanoma (LMM). The prognosis of LMM is similar to that of other subtypes of melanoma and is dependent on the thickness of the tumor (Fig. 31.36A,B).

Nodular Melanoma !!navigator!!

  • The lesion of a nodular melanoma may arise from a pre-existing melanocytic nevus or it may appear de novo as a nodule or plaque (Figs. 31.37 and 31.38). It occurs in 10% to 15% of patients. Because of a rapid vertical growth phase, lesions become invasive at an early stage.

  • Nodular melanoma lesions have the following characteristics:

    • They are blue, blue-black, or nonpigmented (as in amelanotic melanoma); their color is more uniform than that of SSM.

    • May ulcerate and bleed with minor trauma.

    • Occur most commonly on the legs and trunk.

    • May be indistinguishable from a pyogenic granuloma (see Fig. 30.52).

Acral Lentiginous Melanoma !!navigator!!

  • ALM is the least common subtype of melanoma.

  • Although relatively rare compared to other types of melanoma, especially in Caucasians, ALM most often appears in blacks and Asians. It is the most common subtype in people with darker skins. It is not related to sun exposure.

  • Lesions of ALM tend to occur on areas that do not bear hair, such as the palms, soles, and periungual skin (Figs. 31.39 and 31.40).

  • ALM has a tendency toward early metastasis.

  • A subungual ALM presenting as diffuse nail discoloration or a longitudinal pigmented band within the nail plate is potentially confused with subungual hematoma (see Fig. 22.5) or junctional nevus (Fig. 31.41). Pigment spread to the proximal or lateral nail folds (Hutchinson sign) is a hallmark of ALM (Fig. 31.42).

Management-icon.jpg Management

Workup for Patients with Melanoma
  • The most important aspects of the initial workup for patients with cutaneous melanoma are a careful history, review of systems, and physical examination.

  • Recently published data have shown that baseline and surveillance laboratory studies (e.g., lactate dehydrogenase level, liver function tests); chest radiography; and other imaging studies (e.g., computed tomography, positron emission tomography, bone scanning, magnetic resonance imaging) are not typically beneficial for patients without signs or symptoms of metastasis.

  • A metastatic workup should be initiated if physical findings or symptoms suggest disease recurrence or if the patient has documented nodal metastasis based on results from a Sentinel Lymph Node Biopsy (SLNB).

Sentinel Lymph Node Biopsy
  • SLNB is a method used to detect the first lymph node draining from the site of a melanoma.

  • It is generally indicated for pathologic staging of the regional nodal basin(s) for primary tumors of at least 1 mm depth and when certain high-risk histologic features (e.g., ulceration, extensive regression) are present in thinner melanomas.

  • The probability of sentinel node positivity increases with increasing tumor thickness.

  • This minimally invasive procedure allows the pathologist to detect micrometastases.

  • A negative sentinel node obviates the need for further lymph node dissection.

  • Sentinel node status (positive or negative) is the most important prognostic factor for recurrence and is the most powerful predictor of survival in melanoma patients.

Surgical Treatment
  • Elliptic excision should include the entire visible lesion down to the subcutaneous fat.

  • Surgical margins of 5 mm are currently recommended for melanoma in situ.

  • For lesions with a thickness of less than 1 mm, a 1-cm margin of normal skin is usually adequate.

  • Amputation, regional lymph node dissection, and regional chemotherapy perfusion are sometimes necessary for ALMs.

Long-Term Management
  • Patients who have had melanoma should be followed every 3 months for the first 2 years and annually thereafter.

  • At each visit, the patient's entire cutaneous surface and lymph nodes should be examined.

  • Patients with invasive disease require an annual chest radiograph, complete blood count, and liver function studies.

Metastatic Melanoma
  • It is beyond the scope of this discussion to describe the emerging novel therapies for metastatic melanoma; however, there are several targeted therapies with BRAF and MEK inhibitors that are now available have been shown to incrementally increase long-term survival for those with metastatic disease (Figs. 31.43 and 31.44).

Prognosis of Melanoma !!navigator!!

  • Five-year survival is based on the thickness of the tumor on a scale known as the Breslow measurement (Table 31.1). The thickness of the lesion is measured from the top of the granular layer of the skin to the deepest tumor cell. Melanomas that are thicker than 4 mm are associated with a high rate of distant and nodal metastasis.

  • Prognosis may also be determined by the grade of the melanoma, as determined by its location in the dermis using Clark levels (Table 31.2).

  • Sentinel lymph node status is also used for prognostication (see above).

  • Other important prognostic factors include the sex of the patient (women have a better prognosis than men), age (the prognosis worsens with increasing age), and the presence of ulceration or regional or distant spread.

Helpful-Hint-icon.jpg Helpful Hints

  • Trauma from rubbing or irritation does not cause malignant degeneration of moles.

  • Total skin examination that includes the legs should be performed when evaluating a female patient for possible skin cancer.

  • To identify growing lesions, total body photographs allow for the assessment of existing and new lesions anywhere on the body.

  • The use of the “ugly duckling” sign, wherein skin examination is focused on recognition of a lesion that simply looks different from the rest, may assist with detection of lesions that lack the classic ABCDE criteria for melanoma (Figs. 31.45 and 31.46).

  • African-Americans are more likely than whites to be initially seen with advanced disease and have a worse prognosis.

Point-Remember-icon.jpg Points to Remember

  • Sun protection should be stressed in those with a personal or family history of melanoma.

  • Anyone who has a history of melanoma needs lifelong skin surveillance, because 3% of these patients will develop a second melanoma within 3 years.

  • Patients should be taught self-examination.

  • Patients should be advised to have all first-degree relatives undergo a dermatologic examination to check for dysplastic nevi or melanoma.

  • Any lesion that looks suspicious must be examined by biopsy.

  • An amelanotic melanoma is easily overlooked because of its lack of pigmentation.

  • Removal of thin lesions (less than 0.76 mm) is curative in almost all patients.

  • Early detection is the key to saving lives, because the treatments for metastatic melanoma are limited. Once a melanoma is metastatic, there is no uniformly effective adjuvant chemotherapy.

  • No definite proof of survival benefit has been found for performing SLNB versus a group of people who had similar melanomas but no SLNB.

SEE PATIENT HANDOUT “Sun Protection Advice” IN THE COMPANION eBOOK EDITION.


Outline

Diagnosis

  • Clinical diagnosis is based on ABCDE criteria.

  • Elliptic excisional biopsy should include the entire visible lesion.

Diagnosis-icon.jpg Differential Diagnosis

Seborrheic Keratosis (see also Chapter 30: Benign Cutaneous Neoplasms)
  • Particularly if the lesion is variegated in color or jet black.

Pigmented Basal Cell Carcinoma
  • May be clinically indistinguishable from SSM or other types of malignant melanoma (seeFig. 30.27).

Dysplastic or Atypical Nevus (see Chapter 30: Benign Cutaneous Neoplasms)
  • A dysplastic nevus or a melanocytic nevus with an atypical appearance may also be clinically indistinguishable from melanoma.

Other Information

Risk Factors !!navigator!!

  • Persons at greatest risk for melanoma have the following characteristics:

    • Age generally older than 20 years, particularly older than 60 years.

    • A light complexion, an inability to tan, and a history of sunburns.

    • Moles that are numerous, changing, or atypical (dysplastic nevi).

    • A personal or family history of melanoma (first-degree relatives).

    • A personal or family history of BCCs or SCCs.

Histopathology !!navigator!!

  • Superficial spreading melanoma (SSM), lentigo maligna melanoma (LMM), and acral lentiginous melanoma (ALM) have an early in situ (radial growth) phase characterized by increased numbers of intraepithelial melanocytes, which are large and atypical as well as being arranged haphazardly at the dermal-epidermal junction. They show upward (pagetoid) migration and lack the biologic potential to metastasize.

  • Invasion into the dermis may confer metastatic potential and is characterized by a distinct population of melanoma cells with mitoses and nuclear pleomorphism within the dermis (papillary, reticular) and, possibly, the subcutaneous fat.

Distribution of Lesions !!navigator!!

  • In white women, the most common lesion sites for SSM are the upper back, the lower leg between the knees and ankle, and the arms and is less common on covered areas such as under bras and swimsuits.

  • In white men, the most common lesion sites for SSM are the upper back, anterior torso, and the upper extremities.

  • In both white women and white men, other types of melanoma such as lentigo malignant melanoma may occur on the head, neck, and sun-exposed arms. Nodular melanomas tend to arise on the legs and trunk.

  • Melanoma is very rare in dark-skinned persons and Asians. However, when it does occur, it tends to present on acral, non-sun-exposed areas such as the palms of the hands, soles of the feet, or in the nail bed. In such cases, it is referred to as acral lentiginous melanoma (ALM).

Superficial Spreading Melanoma

  • Of the four major clinicopathologic types of melanoma, SSM is by far the most common.

  • SSM may arise de novo or in a pre-existing nevus.

  • The lesions of SSM may conform to some, or all, of the “ABCDE” criteria for melanoma, in which the primary lesion is a macular (flat) lesion or an elevated plaque that displays the following (Figs. 31.29-31.34):

    • A: Asymmetry. If you draw an X and a Y axis through the middle of a lesion and “fold” the lesion on itself, the halves will not match.

    • B: Border that is irregular or notched (like a jigsaw puzzle).

    • C: Color that is varied or has different shades (may have brown, black, pink, blue gray, white, or admixtures of these colors). A blue color results from the Tyndall effect, an optical illusion that occurs when light reflects off brown or black pigment in the deeper layers of the skin. The red color results from an inflammatory response that the immune system is mounting against the tumor. An ivory-white color suggests regression.

    • D: Diameter greater than 6 mm (the size of a pencil eraser), but a lesion may be smaller when first detected.

    • E: Evolution, or change in a pre-existing lesion, that is, any change in size, color, elevation, or any new symptom such as bleeding, itching, or crusting should prompt suspicion.


Outline